WILDI, Karin, Jasper BOEDDINGHAUS, Thomas NESTELBERGER, Raphael TWERENBOLD, Patrick BADERTSCHER, Desiree WUSSLER, Maria Rubini GIMENEZ, Christian PUELACHER, Jeanne du Fay de LAVALLAZ, Sebastian DIETSCHE, Joan WALTER, Nikola KOZHUHAROV, Beata MORAWIEC, Oscar MIRO, Javier F. MARTIN-SANCHEZ, Sinthuri SUBRAMANIAM, Nicolas GEIGY, Dagmar I. KELLER, Tobias REICHLIN, Christian MUELLER, Deborah MUELLER, Lorraine SAZGARY, Stella MARBOT, Zaid SABTI, Dayana FLORES, Kathrin MEISSNER, Caroline KULANGARA, Michael FREESE, Stefan OSSWALD, Claudia STELZIG, Roland BINGISSER, Beatriz LOPEZ, María M. AGUERO, Ewa NOWALANY-KOZIELSKA, Damian KAWECKI, Jiří PAŘENICA, Eva GANOVSKÁ, Jens LOHRMANN, Andreas BUSER, Dayana FLORES, Karin GRIMM, Beate HARTMANN, Piotr MUZYK, Katharina RENTSCH and Arnold von ECKARDSTEIN. Comparison of fourteen rule-out strategies for acute myocardial infarction. International Journal of Cardiology. Clare: Elsevier Ireland Ltd., 2019, vol. 283, MAY 15 2019, p. 41-47. ISSN 0167-5273. Available from: https://dx.doi.org/10.1016/j.ijcard.2018.11.140.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Comparison of fourteen rule-out strategies for acute myocardial infarction
Authors WILDI, Karin (756 Switzerland), Jasper BOEDDINGHAUS (756 Switzerland), Thomas NESTELBERGER (756 Switzerland), Raphael TWERENBOLD (756 Switzerland), Patrick BADERTSCHER (756 Switzerland), Desiree WUSSLER (756 Switzerland), Maria Rubini GIMENEZ (756 Switzerland), Christian PUELACHER (756 Switzerland), Jeanne du Fay de LAVALLAZ (756 Switzerland), Sebastian DIETSCHE (756 Switzerland), Joan WALTER (756 Switzerland), Nikola KOZHUHAROV (756 Switzerland), Beata MORAWIEC (380 Italy), Oscar MIRO (380 Italy), Javier F. MARTIN-SANCHEZ (380 Italy), Sinthuri SUBRAMANIAM (380 Italy), Nicolas GEIGY (756 Switzerland), Dagmar I. KELLER (756 Switzerland), Tobias REICHLIN (756 Switzerland), Christian MUELLER (756 Switzerland, guarantor), Deborah MUELLER (756 Switzerland), Lorraine SAZGARY (756 Switzerland), Stella MARBOT (756 Switzerland), Zaid SABTI (756 Switzerland), Dayana FLORES (756 Switzerland), Kathrin MEISSNER (756 Switzerland), Caroline KULANGARA (756 Switzerland), Michael FREESE (756 Switzerland), Stefan OSSWALD (756 Switzerland), Claudia STELZIG (756 Switzerland), Roland BINGISSER (756 Switzerland), Beatriz LOPEZ (724 Spain), María M. AGUERO (724 Spain), Ewa NOWALANY-KOZIELSKA (616 Poland), Damian KAWECKI (616 Poland), Jiří PAŘENICA (203 Czech Republic, belonging to the institution), Eva GANOVSKÁ (703 Slovakia, belonging to the institution), Jens LOHRMANN (756 Switzerland), Andreas BUSER (756 Switzerland), Dayana FLORES (756 Switzerland), Karin GRIMM (756 Switzerland), Beate HARTMANN (756 Switzerland), Piotr MUZYK (616 Poland), Katharina RENTSCH (756 Switzerland) and Arnold von ECKARDSTEIN (756 Switzerland).
Edition International Journal of Cardiology, Clare, Elsevier Ireland Ltd. 2019, 0167-5273.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.229
RIV identification code RIV/00216224:14110/19:00109666
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.ijcard.2018.11.140
UT WoS 000461330100007
Keywords in English Acute myocardial infarction; Diagnosis; Rule-out; High-sensitivity cardiac troponin T and I; Rule-out algorithm; Efficacy
Tags 14110211, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 16/5/2019 13:41.
Abstract
Background: The clinical availability of high-sensitivity cardiac troponin (hs-cTn) has enabled the development of several innovative strategies for the rapid rule-out of acute myocardial infarction (AMI). Due to the lack of direct comparisons, selection of the best strategy for clinical practice is challenging. Methods: In a prospective international multicenter diagnostic study enrolling 3696 patients presenting with suspected AMI to the emergency department, we compared the safety and efficacy of 14 different hs-cTn-based strategies: hs-cTn concentrations below the limit of detection (LoD), dual-marker combining hs-cTn with copeptin, ESC 0 h/1 h-algorithm, 0 h/2 h-algorithm, 2 h-ADP-algorithm, NICE-algorithm, and ESC 0 h/3 h-algorithm, each using either hs-cTnT or hs-cTnI. The final diagnosis of AMI was adjudicated by two independent cardiologists using all available clinical information including cardiac imaging and serial hs-cTn concentrations. Results: AMI was the final diagnosis in 16% of patients. Using hs-cTnT, safety quantified by the negative predictive value (NPV) and sensitivity was very high (99.8-100% and 99.5-100%) and comparable for all strategies, except the dual-marker approach (NPV 98.7%, sensitivity 96.7%). Similarly, using hs-cTnI, safety quantified by the NPV and sensitivity was very high (99.7-100% and 98.9-100%) and comparable for all strategies, except the dual-marker approach (NPV 96.9%, sensitivity 90.4%) and the NICE-algorithm (NPV 99.1%, sensitivity 94.7%). Efficacy, quantified by the percentage of patients eligible for rule-out, differed markedly, and was lowest for LoD-algorithm (15.7-26.8%). Conclusion: All rapid rule-out algorithms, except the dual-marker strategy and the NICE-algorithm using hs-cTnI, favorably combine safety and efficacy, and can be considered for routine clinical practice. Clinical trial registration: NCT00470587, http://clinicaltrials.gov/show/NCT00470587. (c) 2018 Elsevier B.V. All rights reserved.
PrintDisplayed: 20/7/2024 12:15